RainDance Technologies Appoints S. Roopom Banerjee as President and Chief Executive Officer

February 3, 2010


Disruptive platform technology enables greater speed, sensitivity, and simplicity for single-cell analysis to accelerate breakthroughs in human health and disease research and diagnostics


LEXINGTON, MASSACHUSETTS, U.S.A. - February 3, 2010 - RainDance Technologies Inc., the leader in sequence enrichment and single-cell analysis, today announced that the Board of Directors has appointed Sirshendu Roopom Banerjee as President and Chief Executive Officer. RainDance Technologies provides innovative microdroplet-based solutions that accelerate research and development for human healthcare and industrial markets. The company provides resolution of molecular, biological, and physiological events from large population samples to unprecedented single-cell analysis, all inside a contained microenvironment that enables quantification, single-molecule sensitivity, and preserves sample integrity with no bias or contamination.

About the appointment, RainDance Director and Managing Partner of Mohr Davidow Ventures Bill Ericson said, "Roopom brings a depth of knowledge and is highly respected in the life science tools and diagnostics industry. Roopom's leadership will enable us to further accelerate the momentum built over the last few years in the adoption of our highly innovative RainStormTM technology, as well as sharpen our focus on new product and technology opportunities in the fields of sequence enrichment and single-cell analysis."

Most recently, Mr. Banerjee was a Director of Healthcare Investment Banking at Leerink Swann, where he led the Life Science Tools and Diagnostics sector. Previously, Mr. Banerjee was with McKinsey and Goldman Sachs advising Fortune 500 healthcare companies globally on corporate and growth strategy, product development and launch strategy, international expansion, and mergers and acquisitions. Mr. Banerjee has successfully completed over 50 transactions, including private placements, IPOs, Followons, PIPE/RDs, and fixed income as well as mergers and acquisitions.

Earlier in his career, Mr. Banerjee worked at the Dana Farber Cancer Institute, the Whitehead Institute/M.I.T. Human Genome Project, and at the Massachusetts General Hospital Cancer Center. Mr. Banerjee holds an M.P.P. from the Kennedy School of Government at Harvard University and dual B.S. degrees in Biology and Economics from M.I.T., where he was elected a Howard Hughes Medical Institute Scholar.

"This is a significant time to join RainDance, with the company experiencing breakthrough sales growth. We are seeing strong customer demand for our novel products in sequence enrichment, such as rare variant analysis, as well as future applications in methylation and ultra-deep sequencing. RainDance is truly platform-agnostic and capitalizing on the explosive growth across next-generation sequencing," said Banerjee. "Beyond sequence enrichment, we have demonstrated unique capabilities in digital PCR as well as protein, antibody, and single-cell applications. I am excited to be joining a high-caliber team with a proven track record of execution in these areas."

Christopher McNary, who has served RainDance as CEO since November 2007, will join Mr. Banerjee on the senior executive team as Chief Commercial Officer and will focus on moving the company into high-growth commercialization. Mike Hunkapiller, General Partner at Alloy Ventures and Director at RainDance said, "Chris has brought strong leadership and operating experience to guide RainDance from technology-stage through commercial launch of our flagship RDT 1000 product. We are excited that Chris is turning his focus to leading the commercial charge for RainDance. RainDance is uniquely poised to unlock large latent markets and address unmet customer needs for single-cell analysis."


About RainDance Technologies

RainDance Technologies' proprietary technology platform delivers exquisite sensitivity and data quality that inspires scientists, researchers, and clinicians to rethink the way they design experiments, approach discovery, or conduct clinical diagnostics. The core RainStorm technology empowers customers to conduct de novo science in an ultra-high throughput, simple, flexible, and low-cost manner. RainDance's commercial products include instruments and high-value consumables and reagents for sequence enrichment for next-generation sequencing, ultra-deep sequencing, and methylation analysis. RainDance sells directly in the U.S. and in Europe, and is building distribution networks in Europe and Asia-Pacific. RainDance Technologies, with headquarters in Lexington, Massachusetts, and a European sales office in the United Kingdom, has approximately 70 employees worldwide. For more information, please visit www.raindancetech.com.


RainStorm is a trademark of RainDance Technologies, Inc.



Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.